Companies formed

Since 1997, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and has spun out a new company every two months on average.

Over £2.1bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and eleven are currently listed in London and New York.

The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.

2020

A lean spin-out, social enterprise focusing on developing a fast rapid COVID-19 test. Joint Oxford University and OSCAR company.

Incorporated in June 2020

Origin: Oxford University, Engineering

Contact: Jane Jin

High heat flux technology. The company will provide advanced engineering solutions to challenging thermal problems such as those that occur in fusion reactors, or high power density electronic systems.

Incorporated in April 2020

Origin: Oxford University, Thermofluids Institute

Contact: Adrian Coles

Development of a platform for the standardisation of assetments to facility language, reading and arithmetic skills in children.

Incorporated in April 2020

Origin: Oxford University, Education

Improving the lives of people living with Parkinson’s.

Incorporated in March 2020

Origin: Oxford University, Physiology, Anatomy and Genetics

Contact: Richard Auburn

2019

GryeOx addresses significant unmet need in drug discovery as the IP can make expanded drug libra of macrocycles in the hit to lead stage.

Incorporated in July 2019

Origin: Oxford University

DNA assembly.

Incorporated in July 2019

Origin: Oxford University

Platform technology based on NG capture-c technique computational pipelines and experimental know-how.

Incorporated in July 2019

Origin: Oxford University, MRC Weatherall Institute of Molecular Medicine

Contact: Matthew Carpenter

"CRIS" software that enables submission, de-identification and sharing of mental health patient records using a federated data and information governance model.

Incorporated in May 2019

Origin: Oxford University, Psychiatry

To develop compound libraries based on the asymmetric synthesis methodolofies.

Incorporated in March 2019

Origin: Oxford University, Chemistry

2018

Will produce a new, scalable route to Cannabidiol.

Incorporated in December 2018

Origin: Oxford University, Chemistry

OxStem Immuno aims to develop small molecule drugs that augment macrophage efferocytosis in
vitro and enhance tissue repair in vivo. These therapies will supercede the need for cell transplantation
or cytokine therapy in the context of tissue repair for chronic wounds and a range of inflammatory
conditions.

Incorporated in December 2018

Origin: Oxford University, Department of Physiology, Anatomy and Genetics

Contact: Adam Workman

Search

Ready to get in touch?

Contact Us
Search
© Oxford University Innovation